Tag Archive for: pneumococcal vaccine

As vaccines for COVID-19 and, for older people, RSV and pneumococcal disease join the annual flu shot as routine care recommendations for adults, healthcare professionals are increasingly concerned over getting the word out, vaccine fatigue and logistical hurdles. Biopharma companies are betting there will be a market for vaccines that combine protection against two or more diseases in a single jab.

Two late-stage trial wins for Merck’s investigational pneumococcal vaccine V116 could make it a serious challenger to Pfizer’s Prevnar 20 in the space.